Comparison of treatment planning, quality assurance and treatment implementation of Stereotactic Radiotherapy (SRT) with and without the use of Micro Multileaf Collimator (mMLC).
Not Applicable
- Conditions
- Health Condition 1: R688- Other general symptoms and signs
- Registration Number
- CTRI/2021/11/037842
- Lead Sponsor
- RECHAL NISHA DSOUZA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
CT scans of patients undergoing SRT treatment.
Exclusion Criteria
Patients unfit for Radiation therapy and being considered for hypofractionated brachytherapy procedures
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢Dosimetric Comparison of Stereotactic Radiotherapy (SRT) Treatment plan with and without the use of Micro Multileaf Collimator (mMLC)Timepoint: 18 months
- Secondary Outcome Measures
Name Time Method â?¢Comparison of radiation detectors for patient-specific QA using pinpoint ionization chamber, micro-diamond detector, SRS diode detector, and 4D Octavius array detector for the plans with and without mMLC. <br/ ><br>â?¢Identifying the factors affecting performance of mMLC and non-mMLC SRT techniques. <br/ ><br>â?¢Comparison of mMLC and non mMLC techniques with regards to the practical aspects of treatment delivery. <br/ ><br>Timepoint: 18 months